. Correction to: Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy by Wadsley et al. Thyroid 2023;33(9):1119-1123; doi: 10.1089/thy.2022.0707. Thyroid 2023 Oct 19. doi: 10.1089/thy.2022.0707.
PMID: 37856079